| 1 |
32970826 | Clopidogrel Dosing: Current Successes and Emerging Factors for Further Consideration. | 2021 May |
1 |
| 2 |
29696643 | Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. | 2019 Jan |
1 |
| 3 |
28258380 | Clinical Pharmacokinetics of Dasabuvir. | 2017 Oct |
2 |
| 4 |
28411400 | Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir. | 2017 Oct |
1 |
| 5 |
28444890 | Utilizing PBPK Modeling to Evaluate the Potential of a Significant Drug-Drug Interaction Between Clopidogrel and Dasabuvir: A Scientific Perspective. | 2017 Oct |
2 |
| 6 |
28483778 | Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir. | 2017 Jul |
2 |
| 7 |
26721703 | Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. | 2016 Jan |
1 |
| 8 |
27179126 | Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans. | 2016 Aug |
1 |